Dr Krishna Ella
- All
- News
- Videos
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Chief Justice Stresses On Respecting Mother, Mother Tongue And Motherland
Chief Justice of India NV Ramana on Thursday presented the Dr Ramineni Foundation's awards to vaccine maker Bharat Biotech's MD Krishna Ella and several others for their meritorious services.
-
Booster Dose Required If Covid Virus Gets Mutated: Bharat Biotech Chief
People will need booster doses of the COVID-19 vaccine would be required if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
-
"Significant Success": Bharat Biotech Lauds Government Over 100 Crore Jabs
As India on Thursday achieved the milestone of administering 100 crore COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.
-
"Proud To Have Contributed": Bharat Biotech On 1 Billion Covid Jab Feat
As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'.
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Chief Justice Stresses On Respecting Mother, Mother Tongue And Motherland
Chief Justice of India NV Ramana on Thursday presented the Dr Ramineni Foundation's awards to vaccine maker Bharat Biotech's MD Krishna Ella and several others for their meritorious services.
-
Booster Dose Required If Covid Virus Gets Mutated: Bharat Biotech Chief
People will need booster doses of the COVID-19 vaccine would be required if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
-
"Significant Success": Bharat Biotech Lauds Government Over 100 Crore Jabs
As India on Thursday achieved the milestone of administering 100 crore COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.
-
"Proud To Have Contributed": Bharat Biotech On 1 Billion Covid Jab Feat
As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'.
